{
    "nctId": "NCT05140252",
    "briefTitle": "Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid",
    "officialTitle": "Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 22,
    "primaryOutcomeMeasure": "Acceptability of Intervention (AIM) Survey",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Early stage breast cancer that is hormone receptor positive (HR+) and human epidermal growth factor negative (HER2-)\n* Meet criteria for omission of sentinel lymph node biopsy (SLNB)\n* Receiving care at Michigan Medicine\n\nExclusion Criteria\n\n* Non-English speaking\n* Male patients (current data does not support omission of SLNB in men)",
    "sex": "FEMALE",
    "minimumAge": "70 Years",
    "stdAges": "OLDER_ADULT"
}